Concepedia

Jian Wu

JW

154

Publications

10.5K

Citations

52

H-Index

2003

Active since

Affiliations

Zhejiang University(Current)

First Affiliated Hospital Zhejiang University

Blood Center of Zhejiang Province

Ministry of Public Health

Zhejiang Cancer Hospital

Jian Wu is an author at Zhejiang University specializing in medicine, cancer research, and cell biology.

ORCID

Top concepts

Publications per year

2003–2025

154

Publications

154

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Zhenggang Ren, Jianming Xu, Yuxian Bai et al. · The Lancet Oncology · 2021 · 1K citations

, , +8

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

Yunhao Chen, Chuanhui Peng, Junru Chen et al. · Molecular Cancer · 2019 · 656 citations · Full text

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Jianming Xu, Jie Shen, Shanzhi Gu et al. · Clinical Cancer Research · 2020 · 549 citations · Full text

Liver Transplantation for Hepatocellular Carcinoma

Shusen Zheng, Xiao Xu, Jian Wu et al. · Transplantation · 2008 · 455 citations

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

Shukui Qin, Feng Bi, Shanzhi Gu et al. · Journal of Clinical Oncology · 2021 · 383 citations · Full text

Rows per page

1–5 of 154